The Future of Personalized PALs - Report - MDSpire

The Future of Personalized PALs

Viewing presbyopia management through a new lens

  • By

  • Griffith Altmann

  • July 14, 2026

  • 6 min

Share

Clinical Report: The Future of Personalized PALs

Background

Presbyopia affects adults over 45, impacting their independence and quality of life. Conventional PALs, while common, often lead to adaptation difficulties and do not account for individual visual behaviors and needs. Understanding these factors is crucial for improving presbyopia management.

Data Highlights

In a survey of 3,277 patients wearing PALs, nearly half reported near distance focusing difficulties, and a third had to move their head to focus at near or middle distances.

Key Findings

  • Conventional PALs may not adapt well for nearly half of patients.
  • Visual Sensory Intelligence varies significantly among individuals, affecting their visual needs.
  • Hoyalux iD MySense lenses are designed to integrate refractive data with behavioral measurements.
  • Precise measurements and adaptation counseling are critical for successful PAL fitting.

Clinical Implications

Eye Care Professionals should consider individual visual behaviors and preferences when prescribing PALs.

Conclusion

The shift towards personalized PAL designs focuses on individual patient needs.

Related Resources & Content

  1. Eyecare Business, Eyecare Business, 2019 -- Bespoke Vision
  2. Eyecare Business, Eyecare Business, 2009 -- PAL Update
  3. Eyecare Business, Eyecare Business, 2006 -- True Believers: Converting Seniors from Bifocals to PALs
  4. BCLA CLEAR Presbyopia consensus series, 2024 -- Summary of findings
  5. Eyecare Business — Solutions: Working with PALs
  6. https://pure.ulster.ac.uk/ws/files/173654654/1-s2.0-S136704842400050X-main.pdf
  7. An objective measurement approach to quantify the perceived distortions of spectacle lenses | Scientific Reports

Original Source(s)

The Future of Personalized PALs

  • by Griffith Altmann

  • July 14, 2026

Related Content

YUVEZZI Campaign Targets Presbyopia

Tenpoint Therapeutic’s new national campaign uses puppet characters to spotlight the everyday frustrations of presbyopia

  • July 13, 2026

  • 2 min
New Medications for Dry Eye and Presbyopia

Topical miotics are approved for use in all adults with presbyopia, including post-LASIK patients and pseudophakes, and acoltremon is a treatment option for multiple dry eye subtypes, either as primary therapy or adjunctive treatment.

Presbyopia Solutions for Patients With Retinal Disease

When prescribing spectacle lenses, one of the most impactful things we can do is ask: “What are your visual goals?” or more simply, “What are you struggling to see clearly?”